H
Heike Arlt
Researcher at Ludwig Maximilian University of Munich
Publications - 12
Citations - 1249
Heike Arlt is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Cancer & Binding site. The author has an hindex of 10, co-authored 10 publications receiving 1140 citations. Previous affiliations of Heike Arlt include University of Erlangen-Nuremberg.
Papers
More filters
Journal ArticleDOI
The YTA10–12 Complex, an AAA Protease with Chaperone-like Activity in the Inner Membrane of Mitochondria
TL;DR: It is proposed that proteolytic and chaperone-like activities in the YTA10-12 complex mediate assembly and degradation processes of membrane protein complexes and thereby exert key functions in the maintenance of membrane integrity.
Journal ArticleDOI
Molecular Chaperones Cooperate With Pim1 Protease in the Degradation of Misfolded Proteins in Mitochondria
TL;DR: These findings establish a central role of molecular chaperone proteins in the degradation of misfolded proteins by PIM1 protease and demonstrate a functional interrelation between components of the folding machinery and the proteolytic system within mitochondria.
Journal ArticleDOI
The formation of respiratory chain complexes in mitochondria is under the proteolytic control of the m‐AAA protease
TL;DR: An overlapping substrate specificity of the subunits of the m‐AAA protease is revealed and this results explain the impaired assembly of respiratory chain complexes by defects in expression of intron‐containing genes in mitochondria lacking m‐ AAA protease.
Journal ArticleDOI
Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB.
TL;DR: Evidence is provided that a binding site for the cellular transcription factor CREB can also act as a target for IE86 transactivation, showing that at least one specific member of the ATF/CREB family of transcription factors is involved in mediating transactivation by the HCMV IE86 protein.
Journal ArticleDOI
Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
Michael Lampa,Heike Arlt,Timothy He,Beatriz Ospina,Jason Reeves,Bailin Zhang,Joshua Murtie,Gejing Deng,Claude Barberis,Dietmar Hoffmann,Hong Cheng,Jack Pollard,Christopher Winter,Victoria M. Richon,Carlos Garcia-Escheverria,Francisco Adrian,Dmitri Wiederschain,Lakshmi Srinivasan +17 more
TL;DR: This study discovered that loss of GLS function in triple-negative breast cancer (TNBC) cell lines with a deregulated glutaminolysis pathway led to profound tumor growth inhibition in vitro and in vivo and found that GLS inhibition synergizes with mTOR inhibition, which introduces the possibility of a novel therapeutic strategy for TNBC.